![](https://endpts.com/wp-content/uploads/2022/01/Chamath-Palihapitiya-and-Pablo-Legorreta-scaled.jpg)
Chamath Palihapitiya and Pablo Legorreta
Billionaires Chamath Palihapitiya and Pablo Legorreta hatch an $825M SPAC for cell therapy biotech
Three years after Royalty Pharma chief Pablo Legorreta led a group of investors to buy up a pair of biotechs and create a new startup …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.